(DEMANT) Demant - Ratings and Ratios
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0060738599
DEMANT EPS (Earnings per Share)
DEMANT Revenue
DEMANT: Hearing Aids, Hearing Care, Assessment
Demant A/S is a leading global hearing healthcare company with a presence in multiple regions, including Europe, North America, Asia, and the Pacific. The company is a prominent player in the development, manufacturing, and distribution of hearing aids, personalized hearing care products, and hearing and balance assessment solutions for audiologists, ENT doctors, and balance clinics. With a rich history dating back to 1904, Demant A/S has established itself as a pioneer in the hearing healthcare industry, leveraging its expertise to drive innovation and growth. For more information, visit the companys website at https://www.demant.com.
As a key player in the healthcare equipment sector, Demant A/S has demonstrated strong financial performance, with a market capitalization of 55.89 billion DKK. The companys stock is listed as a common stock with the ticker symbol DEMANT, and its country of origin is Denmark. Demant A/S falls under the GICS sub-industry classification of Health Care Equipment, indicating its focus on developing and delivering medical devices and equipment for hearing healthcare.
Analyzing the companys technical data, we observe that the stocks last price was 251.60 DKK, with short-term moving averages (SMA20 and SMA50) indicating a potential consolidation phase. The longer-term SMA200 is at 263.02 DKK, suggesting a possible resistance level. The Average True Range (ATR) is 7.40 DKK, representing a 2.94% daily price movement. The stocks 52-week high and low are 339.00 DKK and 213.60 DKK, respectively, indicating a significant price range.
Combining the technical data with fundamental analysis, we note that Demant A/S has a price-to-earnings (P/E) ratio of 19.70 and a forward P/E of 19.34, suggesting a relatively stable valuation. The companys return on equity (RoE) is 32.47%, indicating strong profitability. Based on these metrics, our forecast suggests that Demant A/S is likely to experience a moderate price movement in the short term, potentially consolidating around the 250 DKK level before breaking out or reversing. A potential trading strategy could involve monitoring the stocks price action around the SMA20 and SMA50 levels, with a possible long position above 256.41 DKK or a short position below 243.03 DKK. However, this forecast is subject to change based on future market and company developments.
Additional Sources for DEMANT Stock
DEMANT Stock Overview
Market Cap in USD | 9,491m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception |
DEMANT Stock Ratings
Growth Rating | 8.55 |
Fundamental | 60.9 |
Dividend Rating | 3.49 |
Rel. Strength | -7.12 |
Analysts | - |
Fair Price Momentum | 254.46 DKK |
Fair Price DCF | 365.69 DKK |
DEMANT Dividends
Currently no dividends paidDEMANT Growth Ratios
Growth Correlation 3m | 49.6% |
Growth Correlation 12m | -52.5% |
Growth Correlation 5y | 14.3% |
CAGR 5y | 9.13% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | -0.13 |
Alpha | -25.75 |
Beta | 0.636 |
Volatility | 31.05% |
Current Volume | 425k |
Average Volume 20d | 248.6k |
As of June 16, 2025, the stock is trading at DKK 281.60 with a total of 424,967 shares traded.
Over the past week, the price has changed by +1.29%, over one month by +8.56%, over three months by +11.83% and over the past year by -11.83%.
Yes, based on ValueRay´s Fundamental Analyses, Demant (CO:DEMANT) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 60.87 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DEMANT is around 254.46 DKK . This means that DEMANT is currently overvalued and has a potential downside of -9.64%.
Demant has no consensus analysts rating.
According to our own proprietary Forecast Model, DEMANT Demant will be worth about 281 in June 2026. The stock is currently trading at 281.60. This means that the stock has a potential downside of -0.2%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 284.3 | 1% |
Analysts Target Price | - | - |
ValueRay Target Price | 281 | -0.2% |